13F GuideFiling Basics
What is SEC Form 13F? Ultimate Guide to Institutional Equity Filings
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
AlphaSMO Research GuideRead Guide
CIK: 0001795097
Total reported value
$544.2M
$544.2M
129 檔
31.2%
At the close of Q2 2024, Privium Fund Management B.V. disclosed equity holdings valued at approximately $544.2M, spread across 129 reported holdings.
During Q2 2024, Privium Fund Management B.V.'s portfolio maintained high stability with no major positional turnover, reflecting a continuous long-term holding approach.
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | TSLA | Tesla Inc | Stock-Consumer Disc | 12.09% | +0.44% | +26.04% | |
| 2 | SPOT | Spotify Technology S.A. | Stock-Comm Services | 12.04% | -2.12% | -11.76% | |
| 3 | AMZN | Amazon.com Inc | Stock-Consumer Disc | 7.15% | +0.71% | — | |
| 4 | SHOP | Shopify Inc - Class A | Stock-Tech | 6.93% | -2.29% | — | |
| 5 | OXY-WS | Occidental Petroleum-cw27 | Stock-Other | 5.13% | — | — | |
| 6 | SNOW | Snowflake Inc | Stock-Tech | 4.68% | — | — | |
| 7 | SE | Sea Ltd-adr | Stock-Comm Services | 3.74% | -2.38% | EXIT | |
| 8 | PLTR | Palantir Technologies Inc-a | Stock-Tech | 2.93% | -1.80% | — | |
| 9 | IONS | Ionis Pharmaceuticals Inc | Stock-Healthcare | 2.85% | +0.13% | +8.93% | |
| 10 | RARE | Ultragenyx Pharmaceutical In | Stock-Other | 2.63% | +0.49% | +16.97% | |
| 11 | ✓ | Proqr Therapeutics N.v. | Stock-Other | 2.35% | +0.05% | +4.42% | |
| 12 | DDOG | Datadog Inc - Class A | Stock-Tech | 2.21% | — | — | |
| 13 | ITCIEUR | Intra-cellular Therapies Inc | Stock-Other | 2.06% | — | +8.36% | |
| 14 | GOOGL | Alphabet Inc-cl A | Stock-Comm Services | 1.89% | — | -33.33% | |
| 15 | ARWR | Arrowhead Pharmaceuticals In | Stock-Healthcare | 1.85% | -1.28% | +4.75% | |
| 16 | NVDA | Nvidia CORP | Stock-Tech | 1.78% | +0.04% | +850.00% | |
| 17 | AMD | Advanced Micro Devices | Stock-Tech | 1.53% | +3.99% | +393.33% | |
| 18 | NET | Cloudflare Inc - Class A | Stock-Tech | 1.52% | — | -6.67% | |
| 19 | CRWD | Crowdstrike Holdings Inc - A | Stock-Tech | 1.50% | — | — | |
| 20 | AXSM | Axsome Therapeutics Inc | Stock-Healthcare | 1.50% | -0.27% | -9.39% | |
| 21 | MRK | Merck & Co. Inc. | Stock-Healthcare | 1.43% | — | -3.74% | |
| 22 | ROIV | Roivant Sciences Ltd. | Stock-Healthcare | 1.30% | — | -14.67% | |
| 23 | RCKT | Rocket Pharmaceuticals Inc | Stock-Other | 1.27% | -0.03% | +6.78% | |
| 24 | ALNY | Alnylam Pharmaceuticals Inc | Stock-Healthcare | 1.22% | -0.21% | -7.18% | |
| 25 | MSFT | Microsoft CORP | Stock-Tech | 1.17% | — | -3.85% | |
| 26 | CPNG | Coupang Inc | Stock-Consumer Disc | 1.08% | — | +2.54% | |
| 27 | ZLAB | Zai Lab Ltd-adr | Stock-Other | 0.96% | -0.09% | -10.34% | |
| 28 | ASTS | AST SpaceMobile, Inc. | Stock-Tech | 0.95% | — | — | |
| 29 | MRNA | Moderna Inc | Stock-Healthcare | 0.69% | +0.07% | -41.64% | |
| 30 | QURE | uniQure N.V. | Stock-Other | 0.65% | +1.12% | +10.62% | |
| 31 | ACAD | Acadia Pharmaceuticals Inc | Stock-Healthcare | 0.60% | — | — | |
| 32 | ALXO | Alx Oncology Holdings Inc | Stock-Other | 0.58% | — | — | |
| 33 | HEI-A | Heico Corp-class A | Stock-Other | 0.54% | — | — | |
| 34 | ✓ | Stock-Other | 0.52% | — | +16.40% | ||
| 35 | CLBT | Cellebrite DI Ltd. | Stock-Other | 0.46% | — | -0.84% | |
| 36 | SMR | NuScale Power Corporation | Stock-Industrials | 0.43% | — | +54.47% | |
| 37 | BIIB | Biogen Inc | Stock-Healthcare | 0.41% | +0.25% | -2.23% | |
| 38 | UAA | Under Armour Inc-class A | Stock-Consumer Disc | 0.37% | — | +1.48% | |
| 39 | CRSP | CRISPR Therapeutics AG | Stock-Healthcare | 0.37% | +0.03% | +114.54% | |
| 40 | ABEV | Ambev Sa-adr | Stock-Consumer Staples | 0.33% | -0.12% | +38.47% | |
| 41 | KRYS | Krystal Biotech Inc | Stock-Healthcare | 0.29% | +0.16% | +42.67% | |
| 42 | BF-B | Brown-forman Corp-class B | Stock-Other | 0.28% | — | — | |
| 43 | PFE | Pfizer Inc | Stock-Healthcare | 0.26% | -0.31% | EXIT | |
| 44 | FOX | Fox CORP - Class B | Stock-Comm Services | 0.25% | — | — | |
| 45 | BYND 0 03-15-27Bond | Beyond Meat Inc | Bond | 0.24% | — | — | |
| 46 | ✓ | Immatics N.v | Stock-Other | 0.23% | — | +18.05% | |
| 47 | RNAGBP | Avidity Biosciences Inc | Stock-Other | 0.22% | — | +176.57% | |
| 48 | FDMT | 4d Molecular Therapeutics In | Stock-Other | 0.21% | -0.11% | +29.03% | |
| 49 | C | Citigroup Inc | Stock-Financials | 0.21% | — | -14.41% | |
| 50 | MGTX | MeiraGTx Holdings plc | Stock-Other | 0.20% | +0.11% | +69.99% |
According to official SEC Form 13F filings, Privium Fund Management B.V. reported a total U.S. public equity portfolio value of $544.2M across 129 disclosed positions in Q2 2024.
Expert Analysis & Guides for Tracking Wall Street Smart Money Movements
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
In terms of portfolio concentration, the top 5 core holdings (including TSLA, SPOT, AMZN) accounted for 31.2% of total reported equity market value during Q2 2024.
During Q2 2024, Privium Fund Management B.V.'s top holdings by market value included TSLA (12.1%)、SPOT (12.0%)、AMZN (7.2%). The largest single position, TSLA, represented 12.1% of total portfolio value.
In Q2 2024, Privium Fund Management B.V. made 0 total portfolio adjustments, initiating 0 new buys, adding to 0 positions, trimming 0 holdings, and fully liquidating 0 stocks.
All holding records on this page are fetched directly from the U.S. Securities and Exchange Commission (SEC) EDGAR system (Form 13F-HR). AlphaSMO parses CUSIP identifiers and formats data into Schema.org-compliant datasets.
Understand SEC Form 4 insider disclosures for corporate officers, directors, and 10% owners to track executive transactions.
Understand Rule 144 restricted stock sale notices to spot planned insider liquidations before market sell pressure arrives.
Explore the 5% beneficial ownership threshold, 13D vs 13G filing differences, and recent SEC accelerated deadline rules.
Best practices for analyzing 13F quarterly changes without getting misled by stock splits, options, or market valuation drift.
Learn how AlphaSMO's flagship signal detects high-conviction stocks where 13F hedge funds and corporate insiders buy at the same time.